ANGELA O'DELL: Open Payments
NPI 1831196120 · MURPHYSBORO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 50 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $304 · 2025 $963
Food & beverage: $963
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $202 |
| Lilly USA, LLC | 5 | $102 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| ABBVIE INC. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Boston Scientific Corporation | 1 | $48 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $40 |
| Exact Sciences Corporation | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: BREZTRI, MOUNJARO, GEMTESA, VRAYLAR, AIRSUPRA, WATCHMAN Access System, Auvelity, NURTEC ODT.
Industry payments across IL — which companies pay providers there.
